MCST and Malta Enterprise launch a EUR 5.3 million COVID-19 R&D Fund

Thursday, April 23, 2020

The World Health Organisation has declared COVID-19 as a Public Health Emergency of International Concern according to the International Health Regulation.

To date, over 2.5 million of confirmed cases of COVID-19 have been reported worldwide including over 170,000 deaths. COVID-19 is affecting over 200 countries and territories around the world, with new cases continuing to emerge daily.

The Malta Council for Science and Technology and Malta Enterprise Corporation have reacted to the challenges surrounding the current unprecedented circumstances by designing a national fund entitled the “COVID-19 R&D Fund”. This initiative has been possible through the support of the Ministry for Finance and Financial Services, and the Ministry for the Economy, Investment and Small Businesses.

The €5.3 Million COVID-19 R&D Fund is to target public, academic and private entities. As a funding mechanism, it will enable R&D on COVID-19 as a departure point, yet with outcomes not only addressing innovative and/or improved approaches related to the current pandemic, but also potential future waves and other antiviral relevant research.

Eligible projects, including those projects having received a COVID-19 specific Seal of Excellence, are those projects that have started on or after 1 February 2020, but not later than 31 December 2020. The duration of the project should be a maximum of eighteen (18) months.

The Rules for Participation for the COVID-19 R&D Fund may be found in the link below.

The Call for applications will follow shortly through the publication of the Application Form and other relevant documentation

------------

The following webinar is scheduled to start on 15th May 2020 at 1:00pm, register now.

COVID-19 Fund Info Session - Non State Aid Route - Webinar

Further Information: External Link